CIAP1/2 are direct E3 ligases conjugating diverse types of ubiquitin chains to receptor interacting proteins kinases 1 to 4 (RIP1-4)

PLoS ONE

Volumn 6, Issue 9, 2011, Pages

  Bertrand, Mathieu J M ^a,b   Lippens, Saskia ^a,b   Staes, An ^a,b   Gilbert, Barbara ^a,b   Roelandt, Ria ^a,b   de Medts, Jelle ^a,b   Gevaert, Kris ^a,b   Declercq, Wim ^a,b   Vandenabeele, Peter ^a,b  

^a DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^b GHENT UNIVERSITY   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INHIBITOR OF APOPTOSIS PROTEIN 1; INHIBITOR OF APOPTOSIS PROTEIN 2; LYSINE; PROTEIN KINASE; RECEPTOR INTERACTING PROTEIN KINASE 1; RECEPTOR INTERACTING PROTEIN KINASE 2; RECEPTOR INTERACTING PROTEIN KINASE 3; RECEPTOR INTERACTING PROTEIN KINASE 4; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG; X LINKED INHIBITOR OF APOPTOSIS; AGFG1 PROTEIN, HUMAN; INHIBITOR OF APOPTOSIS PROTEIN; NUCLEOPORIN; RECEPTOR INTERACTING PROTEIN SERINE THREONINE KINASE; RECEPTOR INTERACTING PROTEIN SERINE THREONINE KINASE 2; RIPK2 PROTEIN, HUMAN; RIPK3 PROTEIN, HUMAN; RNA BINDING PROTEIN; UBIQUITIN; UBIQUITIN PROTEIN LIGASE;

ARTICLE; CELL STRAIN HEK293; CONJUGATION; CONTROLLED STUDY; ENZYME REGULATION; HUMAN; HUMAN CELL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; UBIQUITINATION; AMINO ACID SEQUENCE; CHEMISTRY; METABOLISM;

AMINO ACID SEQUENCE; HEK293 CELLS; HUMANS; INHIBITOR OF APOPTOSIS PROTEINS; NF-KAPPA B; NUCLEAR PORE COMPLEX PROTEINS; RECEPTOR-INTERACTING PROTEIN SERINE-THREONINE KINASE 2; RECEPTOR-INTERACTING PROTEIN SERINE-THREONINE KINASES; RNA-BINDING PROTEINS; UBIQUITIN; UBIQUITIN-PROTEIN LIGASES; X-LINKED INHIBITOR OF APOPTOSIS PROTEIN;

EID: 80052638486     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0022356     Document Type: Article

References (59)

1. Meylan E, Tschopp J, (2005) The RIP kinases: crucial integrators of cellular stress. Trends Biochem Sci 30: 151-159.
2. Cusson-Hermance N, Khurana S, Lee TH, Fitzgerald KA, Kelliher MA, (2005) Rip1 mediates the Trif-dependent toll-like receptor 3- and 4-induced NF-{kappa}B activation but does not contribute to interferon regulatory factor 3 activation. J Biol Chem 280: 36560-36566.
3. Meylan E, Burns K, Hofmann K, Blancheteau V, Martinon F, et al. (2004) RIP1 is an essential mediator of Toll-like receptor 3-induced NF-kappa B activation. Nat Immunol 5: 503-507.
4. Janssens S, Tinel A, Lippens S, Tschopp J, (2005) PIDD mediates NF-kappaB activation in response to DNA damage. Cell 123: 1079-1092.
5. Park JH, Kim YG, McDonald C, Kanneganti TD, Hasegawa M, et al. (2007) RICK/RIP2 mediates innate immune responses induced through Nod1 and Nod2 but not TLRs. J Immunol 178: 2380-2386.
6. Kobayashi K, Inohara N, Hernandez LD, Galan JE, Nunez G, et al. (2002) RICK/Rip2/CARDIAK mediates signalling for receptors of the innate and adaptive immune systems. Nature 416: 194-199.
7. Chin AI, Dempsey PW, Bruhn K, Miller JF, Xu Y, et al. (2002) Involvement of receptor-interacting protein 2 in innate and adaptive immune responses. Nature 416: 190-194.
8. da Silva Correia J, Miranda Y, Leonard N, Hsu J, Ulevitch RJ, (2007) Regulation of Nod1-mediated signaling pathways. Cell Death Differ 14: 830-839.
9. Lu C, Wang A, Dorsch M, Tian J, Nagashima K, et al. (2005) Participation of Rip2 in lipopolysaccharide signaling is independent of its kinase activity. J Biol Chem 280: 16278-16283.
10. Newton K, Sun X, Dixit VM, (2004) Kinase RIP3 is dispensable for normal NF-kappa Bs, signaling by the B-cell and T-cell receptors, tumor necrosis factor receptor 1, and Toll-like receptors 2 and 4. Mol Cell Biol 24: 1464-1469.
11. Zhang DW, Shao J, Lin J, Zhang N, Lu BJ, et al. (2009) RIP3, an energy metabolism regulator that switches TNF-induced cell death from apoptosis to necrosis. Science 325: 332-336.
12. He S, Wang L, Miao L, Wang T, Du F, et al. (2009) Receptor interacting protein kinase-3 determines cellular necrotic response to TNF-alpha. Cell 137: 1100-1111.
13. Cho YS, Challa S, Moquin D, Genga R, Ray TD, et al. (2009) Phosphorylation-driven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammation. Cell 137: 1112-1123.
14. Kasof GM, Prosser JC, Liu D, Lorenzi MV, Gomes BC, (2000) The RIP-like kinase, RIP3, induces apoptosis and NF-kappaB nuclear translocation and localizes to mitochondria. FEBS Lett 473: 285-291.
15. Yu PW, Huang BC, Shen M, Quast J, Chan E, et al. (1999) Identification of RIP3, a RIP-like kinase that activates apoptosis and NFkappaB. Curr Biol 9: 539-542.
16. Moran ST, Haider K, Ow Y, Milton P, Chen L, et al. (2003) Protein kinase C-associated kinase can activate NFkappaB in both a kinase-dependent and a kinase-independent manner. J Biol Chem 278: 21526-21533.
17. Meylan E, Martinon F, Thome M, Gschwendt M, Tschopp J, (2002) RIP4 (DIK/PKK), a novel member of the RIP kinase family, activates NF-kappa B and is processed during apoptosis. EMBO Rep 3: 1201-1208.
18. Holland P, Willis C, Kanaly S, Glaccum M, Warren A, et al. (2002) RIP4 is an ankyrin repeat-containing kinase essential for keratinocyte differentiation. Curr Biol 12: 1424-1428.
19. Rountree RB, Willis CR, Dinh H, Blumberg H, Bailey K, et al. RIP4 regulates epidermal differentiation and cutaneous inflammation. J Invest Dermatol 130: 102-112.
20. Lee TH, Shank J, Cusson N, Kelliher MA, (2004) The kinase activity of Rip1 is not required for tumor necrosis factor-alpha-induced IkappaB kinase or p38 MAP kinase activation or for the ubiquitination of Rip1 by Traf2. J Biol Chem 279: 33185-33191.
21. Nembrini C, Kisielow J, Shamshiev AT, Tortola L, Coyle AJ, et al. (2009) The kinase activity of Rip2 determines its stability and consequently Nod1- and Nod2-mediated immune responses. J Biol Chem.
22. Hasegawa M, Fujimoto Y, Lucas PC, Nakano H, Fukase K, et al. (2008) A critical role of RICK/RIP2 polyubiquitination in Nod-induced NF-kappaB activation. EMBO J 27: 373-383.
23. Ea CK, Deng L, Xia ZP, Pineda G, Chen ZJ, (2006) Activation of IKK by TNFalpha requires site-specific ubiquitination of RIP1 and polyubiquitin binding by NEMO. Mol Cell 22: 245-257.
24. O'Donnell MA, Legarda-Addison D, Skountzos P, Yeh WC, Ting AT, (2007) Ubiquitination of RIP1 regulates an NF-kappaB-independent cell-death switch in TNF signaling. Curr Biol 17: 418-424.
25. Komander D, (2009) The emerging complexity of protein ubiquitination. Biochem Soc Trans 37: 937-953.
26. Tokunaga F, Sakata S, Saeki Y, Satomi Y, Kirisako T, et al. (2009) Involvement of linear polyubiquitylation of NEMO in NF-kappaB activation. Nat Cell Biol 11: 123-132.
27. Haas TL, Emmerich CH, Gerlach B, Schmukle AC, Cordier SM, et al. (2009) Recruitment of the Linear Ubiquitin Chain Assembly Complex Stabilizes the TNF-R1 Signaling Complex and Is Required for TNF-Mediated Gene Induction. Mol Cell 36: 831-844.
28. Gyrd-Hansen M, Meier P, IAPs: from caspase inhibitors to modulators of NF-kappaB, inflammation and cancer. Nat Rev Cancer 10: 561-574.
29. Bertrand MJ, Doiron K, Labbe K, Korneluk RG, Barker PA, et al. (2009) Cellular inhibitors of apoptosis cIAP1 and cIAP2 are required for innate immunity signaling by the pattern recognition receptors NOD1 and NOD2. Immunity 30: 789-801.
30. Varfolomeev E, Goncharov T, Fedorova AV, Dynek JN, Zobel K, et al. (2008) c-IAP1 and c-IAP2 Are Critical Mediators of Tumor Necrosis Factor {alpha} (TNF{alpha})-induced NF-{kappa}B Activation. J Biol Chem 283: 24295-24299.
31. Bertrand MJ, Milutinovic S, Dickson KM, Ho WC, Boudreault A, et al. (2008) cIAP1 and cIAP2 facilitate cancer cell survival by functioning as E3 ligases that promote RIP1 ubiquitination. Mol Cell 30: 689-700.
32. Park SM, Yoon JB, Lee TH, (2004) Receptor interacting protein is ubiquitinated by cellular inhibitor of apoptosis proteins (c-IAP1 and c-IAP2) in vitro. FEBS Lett 566: 151-156.
33. Dynek JN, Goncharov T, Dueber EC, Fedorova AV, Izrael-Tomasevic A, et al. c-IAP1 and UbcH5 promote K11-linked polyubiquitination of RIP1 in TNF signalling EMBO J.
34. Gerlach B, Cordier SM, Schmukle AC, Emmerich CH, Rieser E, et al. Linear ubiquitination prevents inflammation and regulates immune signalling. Nature 471: 591-596.
35. Xu M, Skaug B, Zeng W, Chen ZJ, (2009) A Ubiquitin replacement strategy in human cells reveals distinct mechanisms of IKK activation by TNFalpha and IL-1beta. Mol Cell 36: 302-314.
36. Rahighi S, Ikeda F, Kawasaki M, Akutsu M, Suzuki N, et al. (2009) Specific recognition of linear ubiquitin chains by NEMO is important for NF-kappaB activation. Cell 136: 1098-1109.
37. Blankenship JW, Varfolomeev E, Goncharov T, Fedorova AV, Kirkpatrick DS, et al. (2009) Ubiquitin binding modulates IAP antagonist-stimulated proteasomal degradation of c-IAP1 and c-IAP2(1). Biochem J 417: 149-160.
38. Vanlangenakker N, Vanden BergheT, Bogaert P, Laukens B, Zobel K, et al. cIAP1 and TAK1 protect cells from TNF-induced necrosis by preventing RIP1/RIP3-dependent reactive oxygen species production. Cell Death Differ.
39. DuBridge RB, Tang P, Hsia HC, Leong PM, Miller JH, et al. (1987) Analysis of mutation in human cells by using an Epstein-Barr virus shuttle system. Mol Cell Biol 7: 379-387.
40. Krieg A, Correa RG, Garrison JB, Le Negrate G, Welsh K, et al. (2009) XIAP mediates NOD signaling via interaction with RIP2. Proc Natl Acad Sci U S A 106: 14524-14529.
41. Varfolomeev E, Blankenship JW, Wayson SM, Fedorova AV, Kayagaki N, et al. (2007) IAP antagonists induce autoubiquitination of c-IAPs, NF-kappaB activation, and TNFalpha-dependent apoptosis. Cell 131: 669-681.
42. Zhang D, Lin J, Han J, Receptor-interacting protein (RIP) kinase family. Cell Mol Immunol 7: 243-249.
43. Mahoney DJ, Cheung HH, Mrad RL, Plenchette S, Simard C, et al. (2008) Both cIAP1 and cIAP2 regulate TNFalpha-mediated NF-kappaB activation. Proc Natl Acad Sci U S A 105: 11778-11783.
44. Komander D, Reyes-Turcu F, Licchesi JD, Odenwaelder P, Wilkinson KD, et al. (2009) Molecular discrimination of structurally equivalent Lys 63-linked and linear polyubiquitin chains. EMBO Rep 10: 466-473.
45. Geserick P, Hupe M, Moulin M, Wong WW, Feoktistova M, et al. (2009) Cellular IAPs inhibit a cryptic CD95-induced cell death by limiting RIP1 kinase recruitment. J Cell Biol 187: 1037-1054.
46. Vandenabeele P, Galluzzi L, Vanden Berghe T, Kroemer G, (2010) Molecular mechanisms of necroptosis: an ordered cellular explosion. Nat Rev Mol Cell Biol 11: 700-714.
47. Upton JW, Kaiser WJ, Mocarski ES Virus inhibition of RIP3-dependent necrosis. Cell Host Microbe 7: 302-313.
48. Bhr C, Rohwer A, Stempka L, Rincke G, Marks F, et al. (2000) DIK, a novel protein kinase that interacts with protein kinase Cdelta. Cloning, characterization, and gene analysis. J Biol Chem 275: 36350-36357.
49. Chen L, Haider K, Ponda M, Cariappa A, Rowitch D, et al. (2001) Protein kinase C-associated kinase (PKK), a novel membrane-associated, ankyrin repeat-containing protein kinase. J Biol Chem 276: 21737-21744.
50. Rothe M, Pan MG, Henzel WJ, Ayres TM, Goeddel DV, (1995) The TNFR2-TRAF signaling complex contains two novel proteins related to baculoviral inhibitor of apoptosis proteins. Cell 83: 1243-1252.
51. Li X, Yang Y, Ashwell JD, (2002) TNF-RII and c-IAP1 mediate ubiquitination and degradation of TRAF2. Nature 416: 345-347.
52. Vischioni B, Giaccone G, Span SW, Kruyt FA, Rodriguez JA, (2004) Nuclear shuttling and TRAF2-mediated retention in the cytoplasm regulate the subcellular localization of cIAP1 and cIAP2. Exp Cell Res 298: 535-548.
53. Wu CJ, Conze DB, Li X, Ying SX, Hanover JA, et al. (2005) TNF-alpha induced c-IAP1/TRAF2 complex translocation to a Ubc6-containing compartment and TRAF2 ubiquitination. EMBO J 24: 1886-1898.
54. Csomos RA, Brady GF, Duckett, (2009) Enhanced cytoprotective effects of the inhibitor of apoptosis protein cellular IAP1 through stabilization with TRAF2. J Biol Chem284: 20531-20539.
55. Vince JE, Pantaki D, Feltham R, Mace PD, Cordier SM, et al.(2009) TRAF2 must bind to cellular inhibitors of apoptosis for tumor necrosis factor (tnf) to efficiently activate nf-{kappa}b and to prevent tnf-induced apoptosis. J Biol Chem284: 35906-35915.
56. Li S, Wang L, Dorf ME, (2009) PKC phosphorylation of TRAF2 mediates IKKalpha/beta recruitment and K63-linked polyubiquitination. Mol Cell33: 30-42.
57. Conze DB, Albert L, Ferrick DA, Goeddel DV, Yeh WC, et al.(2005) Posttranscriptional downregulation of c-IAP2 by the ubiquitin protein ligase c- IAP1 in vivo. Mol Cell Biol25: 3348-3356.
58. Mollah S, Wertz IE, Phung Q, Arnott D, Dixit VM, et al.(2007) Targeted mass spectrometric strategy for global mapping of ubiquitination on proteins. Rapid Commun Mass Spectrom21: 3357-3364.
59. Sun X, Lee J, Navas T, Baldwin DT, Stewart TA, et al.(1999) RIP3, a novel apoptosis-inducing kinase. J Biol Chem274: 16871-16875.